Author

C. Sui

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:DNA methylation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Research Focus:protein design· 1

Frequent Co-Authors

C. Liu· 2 shared H. Wang· 2 shared L. Chen· 2 shared W. Zhang· 2 shared Y. Zhu· 2 shared A. Ke· 1 shared B. C.-H. Chiu· 1 shared B. Pitard· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. Liu

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge

S. Sun, E. Li, G. Zhao, J. Tang, Q. Zuo, L. Cai, C. Xu, C. Sui, Y. Ou, C. Liu, H. Li, Y. Ding, C. Li, D. Lu, W. Zhang, , S. Guan

This study shows that peptide-poloxamine-DNA nanoparticles provide complete protection against lethal SARS-CoV-2 challenge through robust mucosal immunity.

bioRxiv · May 29, 2022Immunology

Comprehensive Analysis of Spatial Architecture in Primary Liver Cancer

R. Wu, W. Guo, X. Qiu, S. Wang, C. Sui, Q. Lian, J. Wu, Y. Shan, Z. Yang, S. Yang, T. Wu, K. Wang, Y. Zhu, S. Wang, C. Liu, , L. Chen

This study constructs high-resolution spatial transcriptomes of primary liver cancers to analyze spatial architecture and identify tumor microenvironment features.

bioRxiv · May 24, 2021Cancer Biology

5-Hydroxymethylcytosines from Circulating Cell-free DNA as Diagnostic and Prognostic Markers for Hepatocellular Carcinoma

J. Cai, L. Chen, Z. Zhang, X. Zhang, X. Lu, W. Liu, G. Shi, Y. Ge, P. Gao, Y. Yang, A. Ke, L. Xiao, R. Dong, Y. Zhu, X. Yang, , J. Fan

This study develops a 5-hydroxymethylcytosine (5hmC) diagnostic model from circulating cell-free DNA to detect hepatocellular carcinoma with high accuracy and prognostic value.

bioRxiv · Sep 23, 2018 · PreprintCancer Biology